Marzena Ingram

home / authors / marzena-ingram-0

Marzena Ingram is senior manager, quality and compliance at Eurofins CDMO. She led and hosted several cGMP audits, and has diverse quality assurance and technical operations experience.

Articles

Assessing Legacy Drug Quality

Ajay Pazhayattil;Sanjay Sharma;Amol Galande;Marzena Ingram;Robert Rhoades

July 2nd 2021

A data-driven strategy can assess the quality of legacy drugs developed before 2011 process-validation requirements were established.

Lessons from FDA 483s and cGMP Inspection Data

Ajay Babu Pazhayatil;Naheed Sayeed;Marzena Ingram

October 2nd 2019

Production and process controls, organization and personnel were the top problems found, while packaging and labelling citations increased in 2017 and 2018.

Lifecycle-Based Process Validation Emphasizes the Need for Continued Process Verification

Naheed Sayeed-Desta;Ajay Pazhayattil;Marzena Ingram

August 1st 2018

A year’s worth of FDA warning letters suggest that API and finished drug manufacturers should strengthen their approach to continued process verification.